You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Claims for Patent: 10,532,036

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,532,036

Title:	Combination composition
Abstract:	A combination pharmaceutical composition for the treatment of pain including about 125 mg to about 150 mg ibuprofen and about 475 mg to about 500 mg paracetamol.
Inventor(s):	Hartley Campbell ATKINSON
Assignee:	AFT Pharmaceuticals Ltd
Application Number:	US13/857,802
Patent Claims:	1. A method for treating acute pain comprising administering 250 mg to 300 mg ibuprofen and 975 mg to 1000 mg paracetamol in a single administration, wherein the ratio of paracetamol to ibuprofen administered is 50:15 and the administration comprises administering tablets or capsules, wherein each tablet or capsule comprises both ibuprofen and paracetamol and the ratio of paracetamol to ibuprofen in each tablet or capsule is 50:15. 2. The method of claim 1, comprising administering 300 mg ibuprofen and 1000 mg paracetamol in the single administration. 3. The method of claim 1, comprising administering 292.5 mg ibuprofen and 975 mg paracetamol in the single administration. 4. The method of any of claims 1-3, wherein the administration occurs four times daily.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.